Perspective Therapeutics, Inc.CATXNYSE

Revenue (LTM)

Net Income (LTM)

$-103M

-30.1% YoY

Free Cash Flow

$-95M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Jun 22	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	11	7↓34.2%	1↓79.8%	0	0
Gross Profit	5	2↓64.6%	1↓12.2%	0	0
Operating Income	-7	-15↓105.4%	-41↓169.7%	10↑125.5%	9↓12.6%
Net Income	-7	-15↓105.1%	-47↓217.0%	-79↓70.5%	-103↓30.1%
EBITDA	-7	-15↓100.8%	-40↓169.3%	10↑126.2%	9↓12.6%
EPS Diluted	-0.13	-0.27↓107.7%	-0.85↓214.8%	-1.23↓44.7%	-1.40↓13.8%

Metric	Jun 22	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	60	21↓65.2%	9↓56.0%	62↑566.6%	31↓50.3%
Total Current Assets	64	53↓16.3%	17↓68.4%	231↑1272.9%	148↓35.8%
Total Assets	67	58↓13.6%	98↑68.5%	341↑248.4%	267↓21.7%
Total Current Liabilities	2	3↑45.0%	16↑485.4%	18↑16.4%	29↑57.3%
Total Liabilities	3	3↑20.6%	23↑558.5%	50↑122.1%	60↑18.9%
Total Equity	64	55↓15.1%	75↑37.6%	291↑286.6%	207↓28.8%
Total Debt	1	0	3	4↑59.2%	2↓59.9%
Net Debt	-60	-21↑64.8%	-7↑68.1%	-58↓760.1%	-29↑49.6%

Metric	Jun 22	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-8	-12↓57.9%	-37↓203.3%	-18↑50.4%	-82↓350.9%
Capital Expenditure	-0	-0↓13.5%	-1↓255.0%	-54↓4975.9%	-13↑76.6%
Free Cash Flow	-8	-12↓56.4%	-38↓204.5%	-73↓91.4%	-95↓31.0%
Stock-Based Comp	1	1↑23.6%	4↑178.1%	5↑44.1%	9↑66.4%
Net Change in Cash	-8	0↑102.3%	-47↓25733.0%	52↑211.8%	-31↓159.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance